Gara Jalqabaatti › Kansarii Ovarii › Ohio › Dayton
Qorannoo klinikaalii Kansarii Ovarii Dayton, OH keessatti
Qorannoo 9 Kansarii Ovarii f Dayton fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Namoota walitti qabaa jiraSadarkaa 2
- Miami Valley Hospital, Dayton
- Premier Blood and Cancer Center, Dayton
- Miami Valley Hospital North, Dayton
- fi 5 dabalataa
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Namoota walitti qabaa jiraSadarkaa 2
- Kettering Medical Center /ID# 274365, Kettering · Miili 5 fagaatti
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Miami Valley Hospital South, Centerville · Miili 9 fagaatti
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Namoota walitti qabaa jiraSadarkaa 3
- Miami Valley Hospital South, Dayton
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
Namoota walitti qabaa jiraSadarkaa 3
- Miami Valley Hospital South, Centerville · Miili 9 fagaatti
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Namoota walitti qabaa jiraSadarkaa 3
- Kettering Health, Kettering · Miili 5 fagaatti
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Namoota walitti qabaa jira
- Miami Valley Hospital, Dayton
- Miami Valley Hospital North, Dayton
- Miami Valley Hospital South, Centerville · Miili 9 fagaatti
- fi 2 dabalataa
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Namoota walitti qabaa jiraSadarkaa 2
- 304, Centerville · Miili 9 fagaatti
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Namoota walitti qabaa jiraSadarkaa 3
- Miami Valley Hospital South, Centerville · Miili 9 fagaatti
Qorannoo Kansarii Ovarii magaalota biroo keessatti
- Houston, TXQorannoo 89
- New York City, NYQorannoo 69
- Boston, MAQorannoo 61
- Los Angeles, CAQorannoo 50
- Nashville, TNQorannoo 49
- Arlington, VAQorannoo 46
- Philadelphia, PAQorannoo 44
- Columbus, OHQorannoo 39
- St. Louis, MOQorannoo 38
- Chicago, ILQorannoo 36
- San Antonio, TXQorannoo 31
- Cleveland, OHQorannoo 30
Qorannoo biroo Dayton keessatti
- Dhibee QaraQorannoo 14
- Kansara Qara'a Non-Small CellQorannoo 13
- Dhukkubaa Harkaa SteatoticQorannoo 8
- Cufama OnneeQorannoo 8
- Kansa EndometiriyaaliiQorannoo 7
- Kansarii ProstateQorannoo 7
- Saree (Gosoota Hunda)Qorannoo 7
- MelanomaQorannoo 7
- ObesityQorannoo 7
- Saree OljooQorannoo 7
- Colitis UlcerativeQorannoo 6
- Baayyee UlfaataaQorannoo 6
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.